AI Approach to Transdermal GLP-1s
February 25, 2025
How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.
3 min read
February 25, 2025
How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.
3 min read
By Alexander Fuchs
January 31, 2025
Doing more to ease the challenges of antibody drug conjugate manufacturing.
3 min read
By Rob Coker
December 24, 2024
So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?
1 min read
December 9, 2024
This roundtable will explore the challenges manufacturers face in this digital age as well as the new technologies and innovations that are setting the standard for the future
10:00 AM US/Eastern min read
November 15, 2024
The Medicine Maker is celebrating its 10-year anniversary! We look back on some of our top articles in biopharma and bioprocessing, from X-ray sterilization for single-use systems, to supply chains for sensitive products, to making biologic...
1 min read
October 3, 2024
In this webinar we will look in depth at the Xcellerex™ magnetic mixer, designed to deliver high performance for even the most challenging large-scale single-use mixing applications.
09:00 AM US/Eastern min read
By Rob Coker
September 26, 2024
AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.
1 min read
By William Boomershine
September 26, 2024
The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible. The health benefits they bring will be worth it.
4 min read
August 29, 2024
The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.
5 min read
By Jungmin Oh
April 29, 2024
Biopharma tech continues to advance so why is downstream processing such a headache? Chromatography, in particular, is an expensive process – but improvements are being made.
4 min read
False
False